Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)

This study has been completed.
Sponsor:
Collaborator:
Fonds de la Recherche en Santé du Québec
Information provided by (Responsible Party):
Karine Bertrand, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT00794391
First received: November 19, 2008
Last updated: April 2, 2014
Last verified: April 2014

November 19, 2008
April 2, 2014
November 2008
August 2011   (final data collection date for primary outcome measure)
Risky injecting practices [ Time Frame: 3 and 6 month follow-ups ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00794391 on ClinicalTrials.gov Archive Site
  • Stages of change for risky injecting practices (adapted from Prochaska & DiClemente) [ Time Frame: 3 and 6 month follow-ups ] [ Designated as safety issue: No ]
  • Drug use (including injecting frequency) [ Time Frame: 3 and 6 months follow-ups ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)
Effects of a Brief Motivational Intervention on Risky Injection Practices Among Injecting Drug Users

The purpose of this study is to evaluate the effects of a brief motivational intervention in reducing risky injection practices among injecting drug users (IDUs). The investigators hypothesis is that motivational intervention will be more effective than educational intervention in reducing risky injection practices among IDUs.

Injecting drug users (IDUs) are among the most vulnerable populations at risk to contract human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Among Canadian cities, Montreal holds one of the higher HIV and HCV contraction rates in the IDU population. Results from SurvUDI, a population survey among IDUs conducted in the province of Quebec (Canada), show that in Montreal 18% of IDUs are infected with HIV and 67% are infected with HCV. The cornerstone of HIV and HCV prevention strategies is to give information on safe injection practices and to make available sterile syringes and other injection equipment. However, the SurvUDI survey reveals that a large proportion of IDUs recruited in community programs offering sterile injection equipment and information on safe injection practices are still sharing needles with other IDUs. Indeed, it seems that information dissemination and distribution of sterile injection equipment are not sufficient in order to control the HIV and HCV epidemic among IDUs. As a matter of fact, it is obvious that complementary interventions such as behavioural interventions are required. Motivational interviewing is an intervention technique centered on the individual. It aims to enhance intrinsic motivation to change behavior by helping the individual to resolve ambivalence. The scientific literature indicates that brief motivational intervention is a significantly effective intervention in order to reduce drug use problems and other related health problems. Furthermore, motivational intervention is well adapted for IDUs' resistance to change and their difficulties related with involvement in long-term therapeutic process. The present study's hypothesis is that IDUs assigned to the experimental group (brief motivational intervention) will present a greater diminution of their risky injection practices in comparison with IDUs assigned to the control group (educational intervention).

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
  • HIV
  • Hepatitis C
  • Behavioral: Motivational interviewing
    Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller & Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
  • Behavioral: Educational intervention
    The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
  • Experimental: Motivational interviewing
    Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller & Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
    Intervention: Behavioral: Motivational interviewing
  • Active Comparator: Educational intervention
    The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
    Intervention: Behavioral: Educational intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
219
August 2011
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • In the last month, at least one cocaine injection
  • In the last month, at least one injection with a syringe or another piece of injection equipment that has been used by someone else
  • 16 years old or more
  • French speaking
  • Being able to give informed consent
Both
16 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00794391
13940 (FRSQ ID)
No
Karine Bertrand, Université de Sherbrooke
Université de Sherbrooke
Fonds de la Recherche en Santé du Québec
Principal Investigator: Karine Bertrand, Ph.D. Université de Sherbrooke
Study Chair: Élise Roy, MD, MSc Université de Sherbrooke
Study Chair: Carole Morissette, MD, FRCPC Université de Montréal & Direction de santé publique de Montréal
Study Chair: Jean-François Boivin, MD, FRCPC McGill University
Université de Sherbrooke
April 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP